Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Stanford University.
Recruitment status was  Recruiting
Genentech, Inc.
Information provided by (Responsible Party):
Pamela L. Kunz, Stanford University Identifier:
First received: October 23, 2008
Last updated: September 3, 2012
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)